MBX Biosciences (MBX) Interest & Investment Income (2023 - 2026)

MBX Biosciences has disclosed Interest & Investment Income across 4 years of filings, most recently posting $3.7 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $3.7 million, up 41.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.2 million (up 53.36% YoY), and the FY2025 annual result was $11.1 million, up 76.72% from the prior year.
• Interest & Investment Income came in at $3.7 million for Q1 2026 at MBX Biosciences, roughly flat from $3.7 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.7 million in Q1 2026 to a low of $783000.0 in Q3 2023.
• The 4-year median for Interest & Investment Income is $2.3 million (2025), against an average of $2.1 million.
• Peak annual rise in Interest & Investment Income reached 198.88% in 2025, while the deepest fall reached 23.45% in 2025.
• MBX Biosciences' Interest & Investment Income stood at $1.1 million in 2023, then soared by 163.41% to $3.0 million in 2024, then increased by 23.45% to $3.7 million in 2025, then gained by 0.4% to $3.7 million in 2026.
• The last three Interest & Investment Income figures came in at $3.7 million (Q1 2026), $3.7 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.